CA3244447A1 - TREATMENT OF HYPERTRIGLYCERIDEMIA WITH 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN - Google Patents
TREATMENT OF HYPERTRIGLYCERIDEMIA WITH 2-HYDROXYPROPYL-BETA-CYCLODEXTRINInfo
- Publication number
- CA3244447A1 CA3244447A1 CA3244447A CA3244447A CA3244447A1 CA 3244447 A1 CA3244447 A1 CA 3244447A1 CA 3244447 A CA3244447 A CA 3244447A CA 3244447 A CA3244447 A CA 3244447A CA 3244447 A1 CA3244447 A1 CA 3244447A1
- Authority
- CA
- Canada
- Prior art keywords
- amount
- subject
- administering
- therapeutically effective
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263311536P | 2022-02-18 | 2022-02-18 | |
| US63/311,536 | 2022-02-18 | ||
| PCT/IB2023/051467 WO2023156970A1 (en) | 2022-02-18 | 2023-02-17 | Treatment of hypertriglyceridemia with 2-hydroxypropyl-beta-cyclodextrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3244447A1 true CA3244447A1 (en) | 2023-08-24 |
Family
ID=85476260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3244447A Pending CA3244447A1 (en) | 2022-02-18 | 2023-02-17 | TREATMENT OF HYPERTRIGLYCERIDEMIA WITH 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240398849A1 (https=) |
| EP (1) | EP4479064A1 (https=) |
| JP (1) | JP2025508660A (https=) |
| KR (1) | KR20240148426A (https=) |
| CN (1) | CN118715017A (https=) |
| AU (1) | AU2023222567A1 (https=) |
| CA (1) | CA3244447A1 (https=) |
| IL (1) | IL315046A (https=) |
| MX (1) | MX2024010110A (https=) |
| TW (1) | TW202342072A (https=) |
| WO (1) | WO2023156970A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003063824A2 (en) * | 2002-02-01 | 2003-08-07 | Shimoda Biotech (Pty) Ltd | Pharmaceutical composition |
| CN1745746A (zh) * | 2004-09-09 | 2006-03-15 | 天津药物研究院 | 冰片的羟丙基－β－环糊精包合物及其制剂和制备方法 |
| CN1961892A (zh) * | 2005-11-08 | 2007-05-16 | 天津药物研究院 | 降香羟丙基－β－环糊精包合物及其制剂和制备方法 |
| GB0710439D0 (en) * | 2007-05-31 | 2007-07-11 | Uni I Oslo | Oral dosage form |
| US8975241B2 (en) * | 2009-10-08 | 2015-03-10 | Song Ho Biomed Co., Ltd. | Composition for treating and preventing obesity including high water-soluble 2-hydroxypropyl-betacyclodextrin as effective component |
| FR3014694B1 (fr) * | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
-
2023
- 2023-02-17 CN CN202380022294.5A patent/CN118715017A/zh active Pending
- 2023-02-17 CA CA3244447A patent/CA3244447A1/en active Pending
- 2023-02-17 AU AU2023222567A patent/AU2023222567A1/en active Pending
- 2023-02-17 WO PCT/IB2023/051467 patent/WO2023156970A1/en not_active Ceased
- 2023-02-17 MX MX2024010110A patent/MX2024010110A/es unknown
- 2023-02-17 EP EP23708901.6A patent/EP4479064A1/en active Pending
- 2023-02-17 KR KR1020247030936A patent/KR20240148426A/ko active Pending
- 2023-02-17 IL IL315046A patent/IL315046A/en unknown
- 2023-02-17 JP JP2024543311A patent/JP2025508660A/ja active Pending
- 2023-02-18 TW TW112105977A patent/TW202342072A/zh unknown
-
2024
- 2024-08-12 US US18/801,161 patent/US20240398849A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024010110A (es) | 2024-08-30 |
| AU2023222567A1 (en) | 2024-09-19 |
| US20240398849A1 (en) | 2024-12-05 |
| JP2025508660A (ja) | 2025-04-10 |
| CN118715017A (zh) | 2024-09-27 |
| EP4479064A1 (en) | 2024-12-25 |
| WO2023156970A1 (en) | 2023-08-24 |
| IL315046A (en) | 2024-10-01 |
| KR20240148426A (ko) | 2024-10-11 |
| TW202342072A (zh) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7835735B2 (ja) | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 | |
| JP2014185161A (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
| US20240398849A1 (en) | Methods for the treatment of hypertriglyceridemia with cyclodextrins | |
| US20230091966A1 (en) | Methods for the treatment of cardiovascular disease with cyclodextrins | |
| US20230375576A1 (en) | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins | |
| García et al. | Anaphylactic shock versus Kounis syndrome in cardiac surgery: Differential diagnosis | |
| CN104507478A (zh) | 用于治疗急性冠状动脉综合征的烟酰胺衍生物 | |
| WO2022047244A1 (en) | Methods for the prevention of cholesterol crystal embolization with cyclodextrins | |
| WO2023014748A1 (en) | Nitrated fatty acids for the treatment of sickle cell disorders | |
| JPWO2007123126A1 (ja) | 慢性心不全における運動耐容能低下の改善剤 | |
| CN119157896A (zh) | 烟酰胺单核苷酸用于制备预防或治疗NT-proBNP异常的药物的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT Effective date: 20240816 |
|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20240820 |
|
| A15 | Pct application entered into the national or regional phase |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240820 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240820 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - SMALL Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250127 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250127 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250127 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250211 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250808 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250813 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250818 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251210 |